REGENLIFE
REGEnLIFE develops a cutting-edge photomedical neurotechnology for the treatment of neurodegenerative diseases. REGEnLIFE is a late-stage medical technology company currently focused on the treatment of Alzheimer's disease and mild traumatic brain injury (which can lead to dementia). The medical device is a patented therapeutic solution based on biophotonics. This non-invasive and painless application targets both the brain and the gut. Recent scientific studies suggest that the brain-gut axis plays a key role in the development of neurodegenerative diseases.
REGENLIFE
Industry:
Health Care Life Science Medical Device Neuroscience
Founded:
2016-01-19
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.regenlife.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Sitelinks Search Box Amazon Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins WPBakery Amazon SSL
Similar Organizations
JPND Research
Joint Programme – Neurodegenerative Disease Research
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Suisse Forme
Med-tech company primarily focused on manufacturing dental aligners
Vamstar
AI-powered Global B2B Healthcare Marketplace
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Current Employees Featured
Founder
Official Site Inspections
http://www.regenlife.com
- Host name: server-3-167-37-71.iad61.r.cloudfront.net
- IP address: 3.167.37.71
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
